Skip to content

Curative effect and preliminary mechanism of Huangbai Liniment in treating patients with abdominal abscess

Curative effect and preliminary mechanism of Huangbai Liniment in treating patients with abdominal abscess

Status
Unknown
Phases
Phase 2
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200056082
Enrollment
Unknown
Registered
2022-01-31
Start date
2022-01-25
Completion date
Unknown
Last updated
2024-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abdominal abscess

Interventions

Control group:Gentamicin injection
Observation group:Huangbai Liniment

Sponsors

117 Mei shan road, Hefei, Anhui, China
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients with abdominal abscess admitted to the General Surgery Department of our hospital were aged between 20 and 80 years old; 2. B ultrasound, CT or MRCP diagnosis of abdominal abscess is sure; 3. It accords with the diagnosis of TCM syndrome; 4. The expected survival time is more than 12 months; 5. Volunteer to join the investigator and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Allergic to this medicine; 2. Severe cardiopulmonary diseases or coagulation disorders; 3. Patients were discharged or transferred to another hospital early after surgery, and follow-up records were not perfect; 4. The patients had severe neuropsychiatric symptoms and poor treatment compliance.

Design outcomes

Primary

MeasureTime frame
White blood cells;Neutrophils;Complement 3;C-reactive protein;Tumor necrosis factor-a;Interleukin-1;Interleukin-6;The volume of the abscess;

Secondary

MeasureTime frame
Body temperature;Heart rate;Pain;

Countries

hina

Contacts

Public ContactQingsheng Yu

The First Affiliated Hospital of Anhui University of Chinese Medicine

sy6312@163.com+86 13866141906

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026